{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:00:21Z","timestamp":1771513221125,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-05821-3","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:32:13Z","timestamp":1771011133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Agent-based simulation of seasonal malaria chemoprevention strategy in Southern Tanzania: comparing dihydroartemisinin-piperaquine with or without primaquine"],"prefix":"10.1186","volume":"25","author":[{"given":"Celina Theophil","family":"Mfala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devotha Godfrey","family":"Nyambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Owden","family":"Mwaiswelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Tchuenche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Clemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"5821_CR1","volume-title":"World malaria report 2023","author":"WHO","year":"2023","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"5821_CR2","volume-title":"World Malaria Report 2024","author":"WHO","year":"2024","unstructured":"WHO. World Malaria Report 2024. Geneva: World Health Organization; 2024."},{"key":"5821_CR3","volume-title":"World Malaria Report 2020","author":"WHO","year":"2020","unstructured":"WHO. World Malaria Report 2020. Geneva: World Health Organization; 2020."},{"key":"5821_CR4","volume-title":"Evidence Review Group: The Safety and Effectiveness of Single Dose Primaquine as a P falciparum gametocytocide","author":"WHO","year":"2012","unstructured":"WHO. Evidence Review Group: The Safety and Effectiveness of Single Dose Primaquine as a P falciparum gametocytocide. Bangkok, Thailand: WHO; 2012."},{"issue":"Suppl 4","key":"5821_CR5","first-page":"17","volume":"110","author":"ZD Schneider","year":"2023","unstructured":"Schneider ZD, Shah MP, Boily MC, Busbee AL, Hwang J, Lindblade KA, et al. Mass Drug Administration to Reduce Malaria Transmission: A Systematic Review and Meta-Analysis. Am J Trop Med Hyg. 2023;110(Suppl 4):17\u201329.","journal-title":"Am J Trop Med Hyg"},{"issue":"10265","key":"5821_CR6","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","volume":"396","author":"E Baba","year":"2020","unstructured":"Baba E, et al. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa\u202f: an observational study. Lancet. 2020;396(10265):1829\u201340.","journal-title":"Lancet"},{"issue":"1","key":"5821_CR7","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41598-024-52706-z","volume":"14","author":"RO Mwaiswelo","year":"2024","unstructured":"Mwaiswelo RO, Ngasala B, Chaky F, Molteni F, Mohamed A, Lazaro S, et al. Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania. Sci Rep. 2024;14(1):2143.","journal-title":"Sci Rep"},{"issue":"1","key":"5821_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08297-9","volume":"10","author":"P Chotsiri","year":"2019","unstructured":"Chotsiri P, Zongo I, Milligan P, Compaore YD, Som\u00e9 AF, Chandramohan D, et al. Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children. Nat Commun. 2019;10(1):1\u201312.","journal-title":"Nat Commun"},{"issue":"1","key":"5821_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-015-0908-8","volume":"14","author":"K Sundell","year":"2015","unstructured":"Sundell K, Jagannathan P, Huang L, Bigira V, Kapisi J, Kakuru MM, et al. Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children. Malar J. 2015;14(1):1\u20138.","journal-title":"Malar J"},{"issue":"1","key":"5821_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2942-4","volume":"18","author":"P Selvaraj","year":"2019","unstructured":"Selvaraj P, Suresh J, Wenger EA, Bever CA, Gerardin J. Reducing malaria burden and accelerating elimination with long-lasting systemic insecticides: a modelling study of three potential use cases. Malar J. 2019;18(1):307. https:\/\/doi.org\/10.1186\/s12936-019-2942-4.","journal-title":"Malar J"},{"issue":"1","key":"5821_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-022-04434-w","volume":"21","author":"TA Bakai","year":"2022","unstructured":"Bakai TA, Thomas A, Iwaz J, Atcha-Oubou T, Tchadjobo T, Khanafer N, et al. Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020. Malar J. 2022;21(1):1\u201311. https:\/\/doi.org\/10.1186\/s12936-022-04434-w.","journal-title":"Malar J"},{"key":"5821_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-022-00408-5","author":"RO Mwaiswelo","year":"2022","unstructured":"Mwaiswelo RO, Kabuga H, Kweka EJ, Baraka V. Is it time for Africa to adopt primaquine in the era of malaria control and elimination? Trop Med Health. 2022. https:\/\/doi.org\/10.1186\/s41182-022-00408-5.","journal-title":"Trop Med Health"},{"key":"5821_CR13","volume-title":"Guideline WHO Guidelines for malaria","author":"WHO","year":"2021","unstructured":"WHO. Guideline WHO Guidelines for malaria. Geneva: WHO; 2021."},{"issue":"1","key":"5821_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12916-016-0581-y","volume":"14","author":"BP Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves BP, Tiono AB, Ou\u00e9draogo A, Guelb\u00e9ogo WM, Bradley J, Nebie I, et al. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial. BMC Med. 2016;14(1):40.","journal-title":"BMC Med"},{"key":"5821_CR15","unstructured":"Reddy M, Leong T, Gray A, Kredo T. Single, low dose Primaquine with an Artemisinin-based treatment to reduce P.Falciparum malaria transmission: Evidence review of clinical benefits and harms. 2021."},{"key":"5821_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00479-X","author":"A Dicko","year":"2016","unstructured":"Dicko A, Brown JM, Diawara H, Baber I, Mahamar A, Soumare HM, et al. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial. Lancet Infect Dis. 2016. https:\/\/doi.org\/10.1016\/S1473-3099(15)00479-X.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5821_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12936-016-1341-3","volume":"15","author":"RO Mwaiswelo","year":"2016","unstructured":"Mwaiswelo RO, Ngasala BE, Jovel I, Gosling R, Premji Z, Poirot E, et al. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania. Malar J. 2016;15(1):316. https:\/\/doi.org\/10.1186\/s12936-016-1341-3.","journal-title":"Malar J"},{"key":"5821_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00078-7","author":"D Yilma","year":"2025","unstructured":"Yilma D, Stepniewska K, Bousema T, Drakeley C, Eachempati P, Guerin PJ, et al. Safety and efficacy of single-dose primaquine to interrupt Plasmodium falciparum malaria transmission in children compared with adults: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2025. https:\/\/doi.org\/10.1016\/S1473-3099(25)00078-7.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5821_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2025-020264","volume":"10","author":"T Ye","year":"2025","unstructured":"Ye T, Caspar E, Niyomwungere D, Ouedraogo A, Thiebaut L, Strubel PE, et al. Single low-dose primaquine for malaria control in Africa: A systematic review of safety, efficacy and implementation barriers. BMJ Glob Heal. 2025;10(8):e020264.","journal-title":"BMJ Glob Heal"},{"key":"5821_CR20","unstructured":"NMCP. National guidelines for malaria diagnosis, treatment and preventive therapies 2020. 2020."},{"key":"5821_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijgi9090549","author":"NM Gharakhanlou","year":"2020","unstructured":"Gharakhanlou NM, Hooshangi N, Helbich M. A spatial agent-based model to assess the spread of malaria in relation to anti-malaria interventions in southeast Iran. ISPRS Int J Geo-Inf. 2020. https:\/\/doi.org\/10.3390\/ijgi9090549.","journal-title":"ISPRS Int J Geo-Inf"},{"key":"5821_CR22","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2021041","author":"OA Okunlola","year":"2021","unstructured":"Okunlola OA, Oyeyemi OT, Lukman AF. Modeling the relationship between malaria prevalence and insecticide-Treated bed net coverage in Nigeria using a Bayesian spatial generalized linear mixed model with a Leroux prior. Epidemiol Health. 2021. https:\/\/doi.org\/10.4178\/epih.e2021041.","journal-title":"Epidemiol Health"},{"issue":"1","key":"5821_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12911-025-03063-y","volume":"25","author":"F Branda","year":"2025","unstructured":"Branda F, Veltri P, Chiodo F, Ciccozzi M, Scarpa F, Guzzi PH. Computational modeling of infectious diseases: insights from network-based simulations on measles. BMC Med Inform Decis Mak. 2025;25(1):238.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"5821_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03721-2","volume":"20","author":"M Amadi","year":"2021","unstructured":"Amadi M, Shcherbacheva A, Haario H. Agent-based modelling of complex factors impacting malaria prevalence. Malar J. 2021;20(1):1\u201315.","journal-title":"Malar J"},{"key":"5821_CR25","doi-asserted-by":"publisher","first-page":"19794","DOI":"10.1109\/ACCESS.2023.3248292","volume":"11","author":"B Modu","year":"2023","unstructured":"Modu B, Polovina N, Konur S. Agent-based modeling of malaria transmission. IEEE Access. 2023;11:19794\u2013808.","journal-title":"IEEE Access"},{"issue":"2","key":"5821_CR26","first-page":"209","volume":"54","author":"S Automatis\u00e9s","year":"2021","unstructured":"Automatis\u00e9s S, Benoudina L, Redjimi M. Multi Agent System Based Approach for Industrial Process Simulation. 2021;54(2):209\u201317.","journal-title":"Multi Agent System Based Approach for Industrial Process Simulation"},{"key":"5821_CR27","unstructured":"Grigoryev I. Anylogic in three days. 2022."},{"issue":"6","key":"5821_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11538-023-01153-4","volume":"85","author":"MN Anwar","year":"2023","unstructured":"Anwar MN, Hickson RI, Mehra S, Price DJ, McCaw JM, Flegg MB, et al. Optimal interruption of P. vivax malaria transmission using mass drug administration. Bull Math Biol. 2023;85(6):1\u201338.","journal-title":"Bull Math Biol"},{"issue":"1","key":"5821_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12936-018-2524-x","volume":"17","author":"MA Kakolwa","year":"2018","unstructured":"Kakolwa MA, Mahende MK, Ishengoma DS, Mandara CI, Ngasala B, Kamugisha E, et al. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania. Malar J. 2018;17(1):369.","journal-title":"Malar J"},{"key":"5821_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.976354","volume":"11","author":"B Ngasala","year":"2023","unstructured":"Ngasala B, Mwaiswelo RO, Chacky F, Molteni F, Mohamed A, Lazaro S, et al. Malaria knowledge, attitude, and practice among communities involved in a seasonal malaria chemoprevention study in Nanyumbu and Masasi districts, Tanzania. Front Public Health. 2023;11:976354.","journal-title":"Front Public Health"},{"issue":"1","key":"5821_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-023-04738-5","volume":"22","author":"EA Liheluka","year":"2023","unstructured":"Liheluka EA, Massawe IS, Chiduo MG, Mandara CI, Chacky F, Ndekuka L, et al. Community knowledge, attitude, practices and beliefs associated with persistence of malaria transmission in North-western and Southern regions of Tanzania. Malar J. 2023;22(1):1\u201316. https:\/\/doi.org\/10.1186\/s12936-023-04738-5.","journal-title":"Malar J"},{"issue":"43","key":"5821_CR32","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.17485\/IJST\/v17i43.2133","volume":"17","author":"CT Mfala","year":"2024","unstructured":"Mfala CT, Nyambo DG, Mwaiswelo RO, Mmbando B, Clemen T. Developing an Agent-based Model for Evaluating the Effectiveness of Malaria Interventions in Nanyumbu and Masasi Districts Tanzania. Indian J Sci Technol. 2024;17(43):4513\u201323.","journal-title":"Indian J Sci Technol"},{"key":"5821_CR33","unstructured":"CDC. CDC\u2013Malaria\u2013About Malaria\u2014Biology. 2021."},{"key":"5821_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.65109\/JPFC9057","volume":"1","author":"A Jindal","year":"2017","unstructured":"Jindal A, Rao S. Agent-based modeling and simulation of mosquito-borne disease transmission. Proc Int Jt Conf Auton Agents Multiagent Syst AAMAS. 2017;1:426\u201335.","journal-title":"Proc Int Jt Conf Auton Agents Multiagent Syst AAMAS"},{"issue":"1","key":"5821_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-023-07274-4","volume":"24","author":"T Nkosi-Gondwe","year":"2023","unstructured":"Nkosi-Gondwe T, Robberstad B, Opoka R, Kalibbala D, Rujumba J, Galileya LT, et al. Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-contro. Trials. 2023;24(1):1\u201314. https:\/\/doi.org\/10.1186\/s13063-023-07274-4.","journal-title":"Trials"},{"issue":"1","key":"5821_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-04021-5","volume":"20","author":"C Ebong","year":"2021","unstructured":"Ebong C, Sserwanga A, Namuganga JF, Kapisi J, Mpimbaza A, Gonahasa S, et al. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. Malar J. 2021;20(1):1\u201312.","journal-title":"Malar J"},{"issue":"23","key":"5821_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192315578","volume":"19","author":"L Pascoe","year":"2022","unstructured":"Pascoe L, Clemen T, Bradshaw K, Nyambo D. Review of importance of weather and environmental variables in agent-based arbovirus models. Int J Environ Res Public Health. 2022;19(23):15578.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"5821_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofad076","volume":"10","author":"C Deng","year":"2023","unstructured":"Deng C, Wu W, Yuan Y, Li G, Zhang H, Zheng S, et al. Malaria control by mass drug administration with artemisinin plus piperaquine on Grande Comore Island, Union of Comoros. Open Forum Infect Dis. 2023;10(3):1\u201311.","journal-title":"Open Forum Infect Dis"},{"key":"5821_CR39","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.2147\/IDR.S375197","volume":"15","author":"S Nikiema","year":"2022","unstructured":"Nikiema S, Soulama I, Sombi\u00e9 S, Tchouatieu AM, Serm\u00e9 SS, Henry NB, et al. seasonal malaria chemoprevention implementation: effect on malaria incidence and immunity in a context of expansion of P. falciparum resistant genotypes with potential reduction of the effectiveness in Sub-Saharan Africa. Infect Drug Resist. 2022;15:4517\u201327.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5821_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03921-w","volume":"20","author":"D Mosha","year":"2021","unstructured":"Mosha D, Kakolwa MA, Mahende MK, Masanja H, Abdulla S, Drakeley C, et al. Safety monitoring experience of single-low dose primaquine co-administered with artemether\u2013lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania. Malar J. 2021;20(1):1\u201310.","journal-title":"Malar J"},{"key":"5821_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008846.pub3\/full","author":"MP Shah","year":"2021","unstructured":"Shah MP, Hwang J, Choi L, Lindblade KA, Kachur SP, Desai M. Mass drug administration for malaria. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD008846.pub3\/full.","journal-title":"Cochrane Database Syst Rev."},{"key":"5821_CR42","unstructured":"WHO. Seasonal malaria chemoprevention. World Heal Organ. 2017."},{"issue":"1","key":"5821_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s13071-018-2977-3","volume":"11","author":"MM Mburu","year":"2018","unstructured":"Mburu MM, Juurlink M, Spitzen J, Moraga P, Hiscox A, Mzilahowa T, et al. Impact of partially and fully closed eaves on house entry rates by mosquitoes. Parasit Vectors. 2018;11(1):383.","journal-title":"Parasit Vectors"},{"issue":"1","key":"5821_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-023-04500-x","volume":"22","author":"D Musoke","year":"2023","unstructured":"Musoke D, Atusingwize E, Namata C, Ndejjo R, Wanyenze RK, Kamya MR. Integrated malaria prevention in low- and middle-income countries: a systematic review. Malar J. 2023;22(1):1\u201337. https:\/\/doi.org\/10.1186\/s12936-023-04500-x.","journal-title":"Malar J"},{"issue":"3","key":"5821_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1473-3099(11)70320-6","volume":"12","author":"K Phiri","year":"2012","unstructured":"Phiri K, Esan M, Van Hensbroek MB, Khairallah C, Faragher B, Ter Kuile FO. Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial. Lancet Infect Dis. 2012;12(3):191\u2013200.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5821_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-018-2972-1","volume":"19","author":"TK Kwambai","year":"2018","unstructured":"Kwambai TK, Dhabangi A, Idro R, Opoka R, Kariuki S, Samuels AM, et al. Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: Study protocol for a multi-centre, two-arm, randomised, placebo-controlled, sup. Trials. 2018;19(1):1\u201312.","journal-title":"Trials"},{"key":"5821_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2022.1058660","volume":"12","author":"B Abuaku","year":"2023","unstructured":"Abuaku B, Boateng P, Peprah NY, Asamoah A, Duah-Quashie NO, Matrevi SA, et al. Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana. Front Cell Infect Microbiol. 2023;12:1\u201311.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5821_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-018-2761-4","volume":"11","author":"JR Ohm","year":"2018","unstructured":"Ohm JR, Baldini F, Barreaux P, Lefevre T, Lynch PA, Suh E, et al. Rethinking the extrinsic incubation period of malaria parasites. Parasit Vectors. 2018;11(1):1\u20139.","journal-title":"Parasit Vectors"},{"issue":"1","key":"5821_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2991-8","volume":"18","author":"AD Mbouna","year":"2019","unstructured":"Mbouna AD, Tompkins AM, Lenouo A, Asare EO, Yamba EI, Tchawoua C. Modelled and observed mean and seasonal relationships between climate, population density and malaria indicators in Cameroon. Malar J. 2019;18(1):1\u201314. https:\/\/doi.org\/10.1186\/s12936-019-2991-8.","journal-title":"Malar J"},{"key":"5821_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05401-x","author":"N Canana","year":"2025","unstructured":"Canana N, Tarquino IAP, Enosse S, Baker K, Rodrigues M, Rassi C, et al. Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis. Malar J. 2025. https:\/\/doi.org\/10.1186\/s12936-025-05401-x.","journal-title":"Malar J"},{"key":"5821_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05220-6","author":"A Kwiringira","year":"2024","unstructured":"Kwiringira A, Kwesiga B, Migisha R, Bulage L, Kadobera D, Rutazaana D, et al. Effect of seasonal malaria chemoprevention on incidence of malaria among children under five years in Kotido and Moroto Districts, Uganda, 2021: time series analysis. Malar J. 2024. https:\/\/doi.org\/10.1186\/s12936-024-05220-6.","journal-title":"Malar J"},{"issue":"9","key":"5821_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1003727","volume":"18","author":"M Cairns","year":"2021","unstructured":"Cairns M, Ceesay SJ, Sagara I, Zongo I, Kessely H, Gamougam K, et al. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: case\u2013control studies in 5 countries. PLoS Med. 2021;18(9):1\u201319.","journal-title":"PLoS Med"},{"issue":"4","key":"5821_CR53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/cid\/cix355","volume":"65","author":"RC Tine","year":"2017","unstructured":"Tine RC, Sylla K, Faye BT, Poirot E, Fall FB, Sow D, et al. Safety and efficacy of adding a single low dose of primaquine to the treatment of adult patients with Plasmodium falciparum malaria in Senegal, to reduce gametocyte carriage: a randomized controlled trial. Clin Infect Dis. 2017;65(4):535\u201343.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5821_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0168702","volume":"12","author":"JT Lin","year":"2017","unstructured":"Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, et al. Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: an open-label randomized trial. PLoS ONE. 2017;12(6):1\u201317.","journal-title":"PLoS ONE"},{"issue":"1","key":"5821_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/ele.12015","volume":"16","author":"EA Mordecai","year":"2013","unstructured":"Mordecai EA, Paaijmans KP, Johnson LR, Balzer C, Ben-Horin T, de Moor E, et al. Optimal temperature for malaria transmission is dramatically lower than previously predicted. Ecol Lett. 2013;16(1):22\u201330.","journal-title":"Ecol Lett"},{"key":"5821_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05368-9","author":"H Merga","year":"2025","unstructured":"Merga H, Degefa T, Birhanu Z, Tadele A, Lee MC, Yan G, et al. Urban malaria in sub-Saharan Africa: a scoping review of epidemiologic studies. Malar J. 2025. https:\/\/doi.org\/10.1186\/s12936-025-05368-9.","journal-title":"Malar J"},{"issue":"8","key":"5821_CR57","first-page":"464","volume":"43","author":"SS Dhruva","year":"2018","unstructured":"Dhruva SS, Ross JS, Desai NR. Real-world evidence: promise and peril for medical product evaluation. Pharm Ther. 2018;43(8):464.","journal-title":"Pharm Ther"},{"issue":"10","key":"5821_CR58","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1513\/AnnalsATS.202005-501PS","volume":"17","author":"AG Buchwald","year":"2020","unstructured":"Buchwald AG, Adams J, Bortz DM, Carlton EJ. Infectious disease transmission models to predict, evaluate, and improve understanding of COVID-19 trajectory and interventions. Ann Am Thorac Soc. 2020;17(10):1204\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"5821_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.chaos.2020.109941","author":"A Bouchnita","year":"2020","unstructured":"Bouchnita A, Jebrane A. A hybrid multi-scale model of COVID-19 transmission dynamics to assess the potential of non-pharmaceutical interventions. Chaos Solitons Fractals. 2020. https:\/\/doi.org\/10.1016\/j.chaos.2020.109941.","journal-title":"Chaos Solitons Fractals"},{"issue":"1","key":"5821_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2442-y","volume":"17","author":"NR Smith","year":"2018","unstructured":"Smith NR, Trauer JM, Gambhir M, Richards JS, Maude RJ, Keith JM, et al. Agent-based models of malaria transmission: a systematic review. Malar J. 2018;17(1):1\u201316. https:\/\/doi.org\/10.1186\/s12936-018-2442-y.","journal-title":"Malar J"},{"key":"5821_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-publhealth-040617-014317","volume":"39","author":"M Tracy","year":"2018","unstructured":"Tracy M, Cerd\u00e1 M, Keyes KM. Agent-based modeling in public health: current applications and future directions. Annu Rev Public Health. 2018;39:77\u201394.","journal-title":"Annu Rev Public Health"},{"key":"5821_CR62","doi-asserted-by":"publisher","DOI":"10.18564\/jasss.5258","author":"AJ Collins","year":"2024","unstructured":"Collins AJ, Koehler M, Lynch CJ. Methods that support the validation of agent-based models: an overview and discussion. Jasss. 2024. https:\/\/doi.org\/10.18564\/jasss.5258.","journal-title":"Jasss"},{"issue":"1","key":"5821_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13721-022-00403-0","volume":"12","author":"SY Tchoumi","year":"2023","unstructured":"Tchoumi SY, Chukwu CW, Diagne ML, Rwezaura H, Juga ML, Tchuenche JM. Optimal control of a two-group malaria transmission model with vaccination. Netw Model Anal Heal Informatics Bioinforma. 2023;12(1):1\u201319. https:\/\/doi.org\/10.1007\/s13721-022-00403-0.","journal-title":"Netw Model Anal Heal Informatics Bioinforma"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05821-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05821-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05821-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:00:18Z","timestamp":1771509618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05821-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5821"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05821-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Kibong\u2019oto Infectious Diseases Hospital- Nelson Mandela African Institution of Science and Technology\u2014Centre for Educational Development in Health, Arusha, with reference number KNCHREC00067\/09\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}